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Abstract In this review, we summarize recent advances in
understanding the etiology, risk factors and pathophysiol-
ogy of focal task specific dystonia (FTSD), movement
disorders characterized by abnormal motor activation dur-
ing the performance of specific, repetitive actions. We
focus on two common FTSD, musician’s dystonia and
writer’s cramp. FTSD may pose a threat to the patient’s
livelihood, and improved therapeutic treatments are
needed.
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Introduction
Dystonias are a diverse ‘‘group of movement disorders
characterized by sustained or intermittent muscle contrac-
tions causing abnormal, often repetitive, movements, pos-
tures, or both’’ [1]. Recently updated consensus opinion
classifies dystonias by two axes: clinical characteristics and
etiology. The first axis, clinical characteristics, includes the
age of onset, affected body region, temporal pattern, and
associated neurologic or systemic features [1]. A subclas-
sification includes focal task specific dystonias (FTSD),
which are a diverse group of focal dystonias affecting an
isolated body part and are triggered, at least initially, by a
specific action.
While the term ‘‘dystonia’’ was first used in 1911 by
Oppenheim, the clinical phenomenon had been described
almost a century earlier in patients with FTSD [2]. In 1830,
clerks in the British Civil Service were noted to develop
difficulty with writing. After observing these clerks, Sir
Charles Bell remarked that he ‘‘found the action necessary
for writing gone, or the motions so irregular as to make the
letters be written zig-zag, whilst the power of strongly
moving the arm for fencing remained…’’ [3]. Later in the
1860s, Samuel Solly labeled this condition ‘‘scrivener’s
palsy’’ [4]. While ‘‘scrivener’s palsy’’ or writer’s cramp, as
it is now called, is one of the more recognized forms of
FTSD, dystonia may affect musicians, typists, hairdressers,
painters, shoemakers and tailors [5–7]. Sport-related FTSD
have also been described in golfers, pistol shooters and
ping-pong players, among others. Because of their associ-
ation with repetitive, fine motor tasks often linked to one’s
profession, FTSD have also been referred to as occupa-
tional dystonias. Interestingly, until the 1980s FTSD were
erroneously interpreted to be psychogenic in origin, often
termed ‘‘occupational neuroses.’’ In 1982, evidence for an
organic etiology emerged from the work of Sheehy and
Marsden [8].
In this review, we discuss the phenomenology and epi-
demiology of two of the most common forms of FTSD,
writer’s cramp and musician’s dystonia. We then discuss
emerging findings on the etiology, pathophysiology and
treatment of FTSD.
Background
FTSD typically begins in adulthood with symptom onset in
the third to sixth decade. Unlike other adult onset primary
focal dystonias, FTSD is more common in men, and it
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usually affects the arm, facial muscles or larynx [9].
Overall prevalence estimates for FTSD in the general
population range from 7 to 69 per million [10, 11]. How-
ever, prevalence has been estimated to be much higher in
selected groups; for instance, some studies have shown as
many as 14% of patients seen at performing arts medical
centers have FTSD [12, 13].
FTSD typically presents as an insidious, painless loss of
dexterity triggered by performance of a specific, often
over-practiced task. Symptoms progress over time to trig-
ger uncontrolled activation of muscle groups, leading to
abnormal postures and movements. Early in the disease
course, the dystonia typically is triggered only by the
performance of a specific task, but over time spreads to
involve other tasks, or even spreads to previously unaf-
fected areas of the body. As with other types of dystonias,
sensory tricks, or geste antagonistes, may temporarily
reduce the dystonic symptoms of FTSD [14].
Writer’s cramp and musician’s dystonia
Writer’s cramp is characterized by involuntary cramping of
muscles of the hand, forearm, or upper arm selectively
triggered by writing. Typically, the distal muscles of the
upper extremity are affected, but dystonia may progress to
include more proximal muscle groups, may be triggered by
other activities, and can even spread to the opposite non-
dominant hand. Average age of onset is in the fourth
decade, and once present, symptoms rarely remit [8].
FTSD seen in musicians, a group that may be at risk due
to overly practiced fine motor tasks, typically manifests in
two phenotypes based on the particular instrument: musi-
cian’s hand dystonia or embouchure dystonia. Musician’s
dystonia can occur in both amateur and professional
musicians, men are affected four times as often as women,
and average symptom onset is in the fourth decade [15].
Musician’s hand dystonia has been reported with a vari-
ety of instruments, including piano, violin, guitar, flute,
clarinet, horn and tabla, among others. Dystonia typically
occurs in the hand that performs the more demanding tasks,
such as the right hand in pianists and the left hand in vio-
linists [16]. The specific pattern of abnormal muscle acti-
vation varies by instrument. For example, abnormal flexion
of the fingers is typically seen in pianists and violinists,
while in woodwind or brass players, extension due to lum-
brical activation can occur [15]. FTSD may be exquisitely
task specific, triggered by playing one instrument, but
sparing the hand when a patient plays a different instrument.
Embouchure dystonia may affect brass and woodwind
players, with age of onset in the fourth decade [6]. The
embouchure is the critical interplay of the lips and facial
muscles with the instrument’s mouthpiece that controls the
production of the desired air stream. Embouchure dystonias
may be further classified by the pattern of abnormal
movements, including embouchure tremor, involuntary lip
movements and jaw closure [6].
Advances in understanding
In recent years, much effort has focused on understanding
the etiology, risk factors and pathophysiology of FTSD and
potential therapeutic interventions. We will review these in
turn.
Etiology
The etiology of FTSD remains unknown, although recent
lines of evidence suggest that both genetic and environ-
mental factors are important [17]. Examination of family
members of patients with FTSD revealed up to 25% of
patients with an affected family member [18, 19]. This is
consistent with a recent study of musician’s dystonia which
found approximately 20% of patients with a similarly
affected family member [20]. A recent genome-wide
analysis has found an association with the arylsulfatase G
(ARSG) gene in both musician’s hand dystonia and wri-
ter’s cramp, but to date, a specific causative mutation
within this gene has not been identified [21, 22]. Addi-
tionally, in a study of musicians with FTSD of the hand,
along with patients with writer’s cramp and their relatives,
reduced interhemispheric inhibition as measured by tran-
scranial magnetic stimulation (TMS) was observed in
individuals where there was a positive family history for
dystonia. This finding suggests that reduced interhemi-
spheric inhibition may serve as a possible endophenotypic
marker of genetic susceptibility for developing FTSD [23].
In addition to repetitive, over-practicing of a motor task,
other environmental factors may contribute to the risk
factors of developing FTSD. Possible risk factors include
personality traits, such as perfectionism and anxiety,
anatomical factors, such as hand size and joint mobility, as
well as delayed onset of age of musical training
[17, 24, 25].
Pathophysiology
The pathophysiology of FTSD has been linked to abnor-
malities in inhibition, plasticity, and motor networks. In
1995, experiments first demonstrated decreased short
intracortical inhibition (SICI) in FTSD patients compared
to healthy controls using TMS [26]. Interestingly, this
abnormality was found in the bilateral hemispheres of
patients, despite unilateral symptoms. Recent research has
therefore postulated that decreased SICI may not directly
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cause abnormal motor activation but rather facilitate the
development of FTSD through other mechanisms [27, 28].
Specifically, one suggested mechanism, found in several
studies of FTSD patients, is the development of impaired
surround inhibition, a neural inhibitory mechanism
responsible for the selective recruitment and activation of
muscles necessary for a particular task with inactivation of
the neighboring muscles that are unnecessary [27, 29, 30].
Consistent with the hypothesis of decreased SICI and
impaired surround inhibition, multiple studies have shown
a loss of dexterity and impaired independent movement of
fingers of patients with either writer’s cramp or musician’s
dystonia [31–33].
Another interesting abnormality that may contribute to
FTSD pathology is maladaptive neural plasticity. While
plasticity is believed to be critical to the processes of
learning and memory, maladaptive neuroplastic responses
in both the motor and sensory cortices have been examined
in conditioning protocols using repetitive stimuli from
TMS [34]. Patients with writer’s cramp exhibited abnormal
responses to paired associative stimulation of the median
nerve and primary motor cortex. Such abnormalities
included increased facilitation with spread to non-median
nerve innervated muscles in addition to the absence of a
typical cortical silent period [35]. More recently, experi-
ments demonstrated a decreased short latency afferent
inhibition following 1-Hz repetitive TMS in writer’s
cramp, but not in normal controls [36].
Furthermore, in both musician’s dystonia and writer’s
cramp, functional neuroimaging experiments have
demonstrated abnormal cortical representations of digits
and reorganization of the sensory homunculus in the sen-
sory cortex [37–39]. Such aberrant somatotopy may be
reversible with associated improved fine motor control
using constraint-induced therapy [40–42]. However,
another study of somatotopic mapping discovered bilateral
misrepresentation of digits despite unilateral dystonic
symptoms, suggesting that the disturbed somatotopy is an
endophenotype for vulnerability to develop FTSD [43].
Regardless of the etiology of the aberrant somatotopy, the
evidence suggests that maladaptive plasticity of FTSD
impairs sensorimotor integration.
Finally, results from recent investigations have suggested
a network disorder leading to FTSD, whereby involvement
of the entire sensorimotor network contributes to dystonia
[44]. Hyperactivation of the basal ganglia has been
demonstrated in fMRI studies of writer’s cramp [45]. Fur-
ther aberrant basal ganglia function has been demonstrated
by PET studies, which have shown decreased release of
striatal dopamine during hand activation in patients with
writer’s cramp [46]. Cerebellar dysfunction has also been
suggested to contribute to FTSD, although the specific
abnormality is not well understood. Some investigations
have reported increased cerebellar activity in patients with
writer’s cramp [47–49], while others have demonstrated
decreased activity in the cerebellum during hand activation
in FTSD [50, 51]. Further research is warranted to under-
stand the precise network abnormalities; however, evidence
of aberrant connections between the basal ganglia and
cerebellum leading to dystonia is supported by research
demonstrating that interruption of this connection leads to
improvement of the dystonic symptoms [52].
Treatment
Current treatment modalities for FTSD include oral medi-
cation, chemodenervation, surgery and physical therapy.
Anticholinergic agents like trihexyphenidyl, as well as
other medications, such as primidone, baclofen, and
phenytoin have been tried with inconsistent responses and
frequent intolerable side effects [53–55]. Chemodenerva-
tion with botulinum neurotoxin (BoNT) type A has been
the mainstay of treatment for FTSD.
Each of the seven known BoNT serotypes (types A–G)
targets a specific SNARE protein for degradation in
peripheral cholinergic neurons, thereby preventing the
downstream release of acetylcholine into the neuromus-
cular junction. As a result, chemodenervation and subse-
quent muscle paralysis occur and persist for several months
until the eventual degradation of BoNT and regeneration of
SNARE proteins [56]. While the inhibition of acetylcholine
release at the neuromuscular junction is believed to be a
major component of BoNT’s mechanism of action, there is
increasing evidence that BoNT also acts peripherally at
gamma motor neurons to reduce afferent sensory input
from muscle spindles to the central nervous system and to
alter sensorimotor pathways [57–61]. Treatment of limb
dystonia with BoNT has demonstrated transient increased
intracortical inhibition on par with normal levels of inhi-
bition as measured by transcranial magnetic stimulation
[62]. Furthermore, recent research suggests that BoNT may
additionally have non-SNARE cellular targets involved in
wide-ranging activities, such as cell division and apoptosis,
neuritogenesis and gene expression [63].
Of the seven BoNT serotypes, only serotype A and to a
lesser extent serotype B are available for clinical use, with
specific formulations of each serotype characterized by
different potency, immunogenicity, preparation, compound
stability and heat tolerance. Notably, BoNT type B is only
formally approved for the treatment of cervical dystonia,
while BoNT type A has approved indications in the treat-
ment of both neurologic and non-neurologic conditions
[64]. Multiple studies have demonstrated long-lasting
treatment benefits of BoNT in FTSD, but there is a delicate
balance between reducing dystonic symptoms without
inducing concurrent residual weakness resulting in loss of
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motor function [53, 65–68]. Even with treatment, many
affected musicians are no longer able to play profession-
ally, due to the high level of fine motor skill required for
continued professional performance.
In recent years, emerging studies have investigated the
role of surgery and sensorimotor retraining as therapeutic
options. Thalamotomies have been performed as treatment
of a variety of movement disorders since the 1950s [69]. In
what was the largest published case series of patients with
writer’s cramp undergoing stereotactic ventro-oral thala-
motomy, eleven of twelve patients reported almost com-
plete resolution of symptoms with sustained benefit for
over one year after surgery [70]. Based on its benefit for
writer’s cramp, stereotactic ventro-oral thalamotomy was
demonstrated to improve medically refractory musician’s
dystonia with long-term benefit [71]. More recently in
2016, treatment with noninvasive gamma knife ventro-oral
thalamotomy was shown to be effective in a case of
refractory musician’s dystonia for a patient who was
deemed too high-risk for conventional stereotactic thala-
motomy [72]. However, larger long-term follow-up studies
will be necessary to evaluate the lasting efficacy of this
intervention. Additionally, a small case series has investi-
gated the role of deep brain stimulation (DBS) in the
treatment of FTSD with promising results [73]. Given the
invasive nature of both thalamotomies and DBS, these
procedures have primarily been reserved for medically
refractory cases.
Based on the idea of excessive motor excitability and
aberrant sensorimotor integration in the development of
FTSD, sensorimotor retraining may hold promise. Previous
attempts at reducing focal dystonia symptoms by means of
rehabilitation involved immobilization and splinting of the
affected body part. Recent studies examining the effects of
augmenting current rehabilitation techniques to include
transcranial direct current stimulation have offered encour-
aging results. In 2014, patients with musician’s dystonia
displayed improvement of fine motor movements following
motor retraining assisted by bi-hemispheric, noninvasive
brain stimulation via transcranial direct current stimulation
to the motor cortex [74]. Likewise, in 2015, transcranial
direct simulation was shown to enhance the response to
rehabilitation in patients with FTSD of the hand in a ran-
domized control trial [75]. Anodal transcranial direct current
stimulation targeting the cerebellum has also been shown to
improve handwriting in patients with writer’s cramp [76].
Conclusion
FTSD are a fascinating group of movement disorders
characterized by aberrant motor overactivation during the
performance of a specific, often over-practiced activity.
The triggering activity can be associated with one’s occu-
pation, leading to the disorder’s further classification as an
occupational dystonia. The development of such a condi-
tion can impact one’s livelihood, particularly if symptoms
are severe. While progress has been made in recent years in
understanding the etiology, risk factors and pathophysiol-
ogy of FTSD, improved therapeutic options are needed.
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